FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+12.17%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$42.4B
AUM Growth
+$4.15B
(+11%)
Cap. Flow
+$478M
Cap. Flow
% of AUM
1.13%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
560
New
84
Increased
175
Reduced
194
Closed
52
Top Buys
| 1 |
Genius Sports
GENI
|
$282M |
| 2 |
Roku
ROKU
|
$266M |
| 3 |
CrowdStrike
CRWD
|
$217M |
| 4 |
Lithia Motors
LAD
|
$169M |
| 5 |
General Motors
GM
|
$164M |
Top Sells
| 1 |
Apple
AAPL
|
$551M |
| 2 |
Qualcomm
QCOM
|
$228M |
| 3 |
Microsoft
MSFT
|
$193M |
| 4 |
ANSS
Ansys
ANSS
|
$184M |
| 5 |
Fiserv
FI
|
$171M |
Sector Composition
| 1 | Technology | 32.2% |
| 2 | Healthcare | 21.46% |
| 3 | Consumer Discretionary | 13.93% |
| 4 | Communication Services | 9.79% |
| 5 | Financials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Comcast
CMCSA
$125B
| $3.28M | 0.01% |
57,517
+823
| +1% | +$46.9K |
|
327
Verizon
VZ
$187B
| $3.26M | 0.01% |
58,089
| – | – |
|
328
Intellia Therapeutics
NTLA
$1.29B
| $3.24M | 0.01% |
20,015
-858
| -4% | -$139K |
|
329
BioMarin Pharmaceuticals
BMRN
$11.1B
| $3.18M | 0.01% |
38,151
+7,711
| +25% | +$643K |
|
330
Doximity
DOCS
$13B
| $3.16M | 0.01% |
+54,225
| New | +$3.16M |
|
|
KRTX
331
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.15M | 0.01% |
27,616
-14,623
| -35% | -$1.67M |
|
332
Cisco
CSCO
$264B
| $3.12M | 0.01% |
58,859
| – | – |
|
|
CNVY
333
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
| $3.08M | 0.01% |
+270,950
| New | +$3.08M |
|
334
Okta
OKTA
$16.1B
| $2.9M | 0.01% |
11,856
-8,171
| -41% | -$2M |
|
335
TG Therapeutics
TGTX
$5.11B
| $2.8M | 0.01% |
72,209
-3,094
| -4% | -$120K |
|
336
Chewy
CHWY
$17.5B
| $2.79M | 0.01% |
+34,947
| New | +$2.79M |
|
|
SIVB
337
DELISTED
SVB Financial Group
SIVB
| $2.66M | 0.01% |
4,776
-20
| -0.4% | -$11.1K |
|
|
ZEN
338
DELISTED
ZENDESK INC
ZEN
| $2.61M | 0.01% |
18,108
-3,866
| -18% | -$558K |
|
339
Coca-Cola
KO
$292B
| $2.59M | 0.01% |
47,892
+524
| +1% | +$28.3K |
|
340
CVS Health
CVS
$93.6B
| $2.55M | 0.01% |
30,602
+689
| +2% | +$57.5K |
|
341
Advance Auto Parts
AAP
$3.6B
| $2.52M | 0.01% |
+12,259
| New | +$2.52M |
|
342
Chevron
CVX
$310B
| $2.46M | 0.01% |
23,499
-13
| -0.1% | -$1.36K |
|
343
Travel + Leisure Co
TNL
$4.08B
| $2.44M | 0.01% |
+41,004
| New | +$2.44M |
|
|
ABMD
344
DELISTED
Abiomed Inc
ABMD
| $2.33M | 0.01% |
7,462
-57,967
| -89% | -$18.1M |
|
345
HCA Healthcare
HCA
$98.5B
| $2.21M | 0.01% |
10,701
+10,449
| +4,146% | +$2.16M |
|
346
Arrowhead Research
ARWR
$4.02B
| $2.2M | 0.01% |
26,554
-4,719
| -15% | -$391K |
|
347
Baker Hughes
BKR
$44.9B
| $2.2M | 0.01% |
+96,001
| New | +$2.2M |
|
|
KDMN
348
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.18M | 0.01% |
562,531
+385,311
| +217% | +$1.49M |
|
349
Bristol-Myers Squibb
BMY
$96B
| $2.15M | 0.01% |
32,181
| – | – |
|
350
Merck
MRK
$212B
| $2.12M | 0.01% |
27,241
-1,308
| -5% | -$102K |
|